

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07003538 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.88657380 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.88657380 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.88657380 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.88657380 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.88657380 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.88657380 |
| 8 | complement activation, alternative pathway (GO:0006957) | 4.56333270 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.53022665 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 4.53022665 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.43075251 |
| 12 | plasma lipoprotein particle clearance (GO:0034381) | 4.37041797 |
| 13 | protein carboxylation (GO:0018214) | 4.36284316 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.36284316 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.29142328 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.29142328 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.29142328 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 4.19931841 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.19931841 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.19154885 |
| 21 | urea metabolic process (GO:0019627) | 4.14653924 |
| 22 | urea cycle (GO:0000050) | 4.14653924 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.08383902 |
| 24 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.08192734 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.07309895 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.00580268 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.97939675 |
| 28 | reverse cholesterol transport (GO:0043691) | 3.96827364 |
| 29 | phospholipid efflux (GO:0033700) | 3.93172332 |
| 30 | regulation of complement activation (GO:0030449) | 3.84633436 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 3.84245387 |
| 32 | regulation of mononuclear cell migration (GO:0071675) | 3.80667777 |
| 33 | regulation of fibrinolysis (GO:0051917) | 3.77921003 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 3.75892335 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 3.73891862 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.69805047 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.69805047 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.69805047 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.68526847 |
| 40 | cholesterol efflux (GO:0033344) | 3.65346985 |
| 41 | cysteine metabolic process (GO:0006534) | 3.61367923 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 3.60435703 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59461362 |
| 44 | regulation of cholesterol storage (GO:0010885) | 3.57454432 |
| 45 | phospholipid homeostasis (GO:0055091) | 3.56547650 |
| 46 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.55030582 |
| 47 | regulation of macrophage chemotaxis (GO:0010758) | 3.54334198 |
| 48 | bile acid metabolic process (GO:0008206) | 3.52562006 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.51995790 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.46643306 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.45221159 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43469804 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.42799953 |
| 54 | aldehyde catabolic process (GO:0046185) | 3.42352178 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.40152465 |
| 56 | response to peptidoglycan (GO:0032494) | 3.35948285 |
| 57 | cellular response to ethanol (GO:0071361) | 3.35580091 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.35467001 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.32180935 |
| 60 | barbed-end actin filament capping (GO:0051016) | 3.31637209 |
| 61 | sulfur amino acid catabolic process (GO:0000098) | 3.28962905 |
| 62 | homocysteine metabolic process (GO:0050667) | 3.28332971 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 3.26277782 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25533854 |
| 65 | response to host immune response (GO:0052572) | 3.25533854 |
| 66 | fibrinolysis (GO:0042730) | 3.24200659 |
| 67 | cellular response to zinc ion (GO:0071294) | 3.22945938 |
| 68 | low-density lipoprotein particle clearance (GO:0034383) | 3.20839517 |
| 69 | positive regulation of lipid catabolic process (GO:0050996) | 3.20709032 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 3.18224008 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.17080208 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.17080208 |
| 73 | regulation of interferon-alpha production (GO:0032647) | 3.13329424 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.12178513 |
| 75 | positive regulation of coagulation (GO:0050820) | 3.11321353 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.11124145 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.11124145 |
| 78 | microglial cell activation (GO:0001774) | 3.10813165 |
| 79 | cellular glucuronidation (GO:0052695) | 3.10787059 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 3.06063762 |
| 81 | cellular response to cadmium ion (GO:0071276) | 3.05968945 |
| 82 | plasma lipoprotein particle organization (GO:0071827) | 3.04798622 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.04774526 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.04180634 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 3.02763166 |
| 86 | protein localization to endosome (GO:0036010) | 3.01331587 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.00722219 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.00722219 |
| 89 | amine catabolic process (GO:0009310) | 2.98062311 |
| 90 | cellular biogenic amine catabolic process (GO:0042402) | 2.98062311 |
| 91 | complement activation (GO:0006956) | 2.97370077 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.97297845 |
| 93 | protein activation cascade (GO:0072376) | 2.96169280 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 2.95508232 |
| 95 | positive regulation of hemostasis (GO:1900048) | 2.95508232 |
| 96 | cofactor catabolic process (GO:0051187) | 2.93468398 |
| 97 | adhesion of symbiont to host cell (GO:0044650) | 2.92996886 |
| 98 | virion attachment to host cell (GO:0019062) | 2.92996886 |
| 99 | lipoprotein metabolic process (GO:0042157) | 2.91779128 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.91387748 |
| 101 | acute-phase response (GO:0006953) | 2.91000493 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 2.90845166 |
| 103 | protein-lipid complex subunit organization (GO:0071825) | 2.87750581 |
| 104 | protein-lipid complex assembly (GO:0065005) | 2.87371785 |
| 105 | complement activation, classical pathway (GO:0006958) | 2.85872134 |
| 106 | response to host (GO:0075136) | 2.85459182 |
| 107 | response to host defenses (GO:0052200) | 2.85459182 |
| 108 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.85459182 |
| 109 | chondroitin sulfate catabolic process (GO:0030207) | 2.85291184 |
| 110 | reactive oxygen species biosynthetic process (GO:1903409) | 2.84972168 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 2.83766006 |
| 112 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79382818 |
| 113 | nucleobase catabolic process (GO:0046113) | 2.77604053 |
| 114 | positive regulation of heat generation (GO:0031652) | 2.75658899 |
| 115 | regulation of fever generation (GO:0031620) | 2.73261563 |
| 116 | amino acid import (GO:0043090) | 2.71275226 |
| 117 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69131881 |
| 118 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.68800026 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66432156 |
| 120 | omega-hydroxylase P450 pathway (GO:0097267) | 2.64945298 |
| 121 | L-amino acid import (GO:0043092) | 2.63559786 |
| 122 | epoxygenase P450 pathway (GO:0019373) | 2.59641058 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.57182033 |
| 124 | glycosphingolipid catabolic process (GO:0046479) | 2.56368340 |
| 125 | regulation of heat generation (GO:0031650) | 2.55772810 |
| 126 | dermatan sulfate biosynthetic process (GO:0030208) | 2.53923786 |
| 127 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.53837992 |
| 128 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.53837992 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.50572114 |
| 130 | dermatan sulfate metabolic process (GO:0030205) | 2.46073332 |
| 131 | glial cell migration (GO:0008347) | 2.45956570 |
| 132 | adhesion of symbiont to host (GO:0044406) | 2.45713049 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44667585 |
| 134 | postsynaptic membrane organization (GO:0001941) | 2.42199520 |
| 135 | response to manganese ion (GO:0010042) | 2.35003234 |
| 136 | positive regulation of cholesterol efflux (GO:0010875) | 2.34838853 |
| 137 | regulation of vitamin metabolic process (GO:0030656) | 2.34799861 |
| 138 | monocyte chemotaxis (GO:0002548) | 2.32084175 |
| 139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27772936 |
| 140 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.26978561 |
| 141 | oligosaccharide catabolic process (GO:0009313) | 2.26711360 |
| 142 | glycolipid catabolic process (GO:0019377) | 2.26501399 |
| 143 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.22429472 |
| 144 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.22085737 |
| 145 | cellular extravasation (GO:0045123) | 2.21147008 |
| 146 | regulation of chemokine biosynthetic process (GO:0045073) | 2.20842012 |
| 147 | negative regulation of cell killing (GO:0031342) | 2.20562185 |
| 148 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.20562185 |
| 149 | positive regulation of sterol transport (GO:0032373) | 2.18659112 |
| 150 | positive regulation of cholesterol transport (GO:0032376) | 2.18659112 |
| 151 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.17076668 |
| 152 | regulation of podosome assembly (GO:0071801) | 2.16641065 |
| 153 | regulation of synapse structural plasticity (GO:0051823) | 2.16573523 |
| 154 | negative regulation of blood coagulation (GO:0030195) | 2.16177336 |
| 155 | negative regulation of hemostasis (GO:1900047) | 2.16177336 |
| 156 | eosinophil chemotaxis (GO:0048245) | 2.14894532 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.14379921 |
| 158 | regulation of monocyte chemotaxis (GO:0090025) | 2.13143432 |
| 159 | ceramide catabolic process (GO:0046514) | 2.11176894 |
| 160 | neuron cell-cell adhesion (GO:0007158) | 2.10196192 |
| 161 | apoptotic cell clearance (GO:0043277) | 2.09782120 |
| 162 | negative regulation of coagulation (GO:0050819) | 2.09267249 |
| 163 | macrophage activation (GO:0042116) | 2.08593571 |
| 164 | macroautophagy (GO:0016236) | 2.08315029 |
| 165 | membrane lipid catabolic process (GO:0046466) | 2.06037423 |
| 166 | exogenous drug catabolic process (GO:0042738) | 2.05714289 |
| 167 | response to magnesium ion (GO:0032026) | 2.05422555 |
| 168 | drug catabolic process (GO:0042737) | 2.04963164 |
| 169 | negative regulation of platelet activation (GO:0010544) | 2.04587881 |
| 170 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.04395016 |
| 171 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.04081089 |
| 172 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.04004929 |
| 173 | response to nerve growth factor (GO:1990089) | 2.04004929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.81850604 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92265561 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.32033629 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26902641 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06606067 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00980341 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90683373 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.39865218 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.35352532 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92556717 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.80527669 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76424637 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.61609438 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58858252 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.46285017 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.44660003 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23820404 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.10688854 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86902143 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86742212 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77526224 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60664884 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59401976 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58741131 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55998982 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53206662 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50094872 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49970068 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48433946 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48433946 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.44207747 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44117930 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43297634 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43297634 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37730312 |
| 36 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37055568 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36478067 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35254175 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34893487 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34690566 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32303344 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30501404 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30381918 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30224476 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25925873 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.23132279 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22644144 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22477434 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21082283 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20510060 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20180704 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20051382 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18111958 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16712649 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16106191 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15690878 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15321074 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14744335 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12068863 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10092035 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08969352 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08816351 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08784632 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08327764 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06779560 |
| 66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.06136001 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05392315 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02893070 |
| 69 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98917315 |
| 70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98088065 |
| 71 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.97692251 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97471824 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96886134 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96832451 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96743979 |
| 76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96086804 |
| 77 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95983471 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95791679 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95758385 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94761133 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94381065 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93282954 |
| 83 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.91523609 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91007588 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90666192 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90069389 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89759845 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89208569 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88290903 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87038986 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84965494 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84662536 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84081598 |
| 94 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84077658 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83597858 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83373988 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83155892 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83079870 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82702294 |
| 100 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82631066 |
| 101 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82535250 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82435287 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82180536 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81603929 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81156772 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81071284 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81017829 |
| 108 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.80697356 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80497036 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80164427 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80100214 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79973800 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79751614 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79672949 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78528371 |
| 116 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78474508 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78099392 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77730279 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76402260 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76348843 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75906522 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75465642 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72425612 |
| 124 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.70102246 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.68867527 |
| 126 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.68282546 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67631034 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.67305099 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67071807 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65716726 |
| 131 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65141861 |
| 132 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64648619 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.64553067 |
| 134 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64291105 |
| 135 | P300_19829295_ChIP-Seq_ESCs_Human | 0.63383915 |
| 136 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63325788 |
| 137 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63315983 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.62853341 |
| 139 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.61795122 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.61139684 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.59437653 |
| 142 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.58552014 |
| 143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58507575 |
| 144 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.58145153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.73908791 |
| 2 | MP0005360_urolithiasis | 5.06188422 |
| 3 | MP0005365_abnormal_bile_salt | 4.31836979 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.01092714 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.33333424 |
| 6 | MP0009840_abnormal_foam_cell | 2.96626432 |
| 7 | MP0005083_abnormal_biliary_tract | 2.73152739 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.72719630 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.66646146 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.64298004 |
| 11 | MP0003252_abnormal_bile_duct | 2.64126909 |
| 12 | MP0003436_decreased_susceptibility_to | 2.61511714 |
| 13 | MP0000604_amyloidosis | 2.58403308 |
| 14 | MP0003195_calcinosis | 2.52896037 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.51902116 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.27780005 |
| 17 | MP0003724_increased_susceptibility_to | 2.05907524 |
| 18 | MP0002419_abnormal_innate_immunity | 2.01285105 |
| 19 | MP0006082_CNS_inflammation | 2.00883861 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.99969010 |
| 21 | MP0003303_peritoneal_inflammation | 1.98606981 |
| 22 | MP0009764_decreased_sensitivity_to | 1.95312524 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.88011726 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.87723034 |
| 25 | MP0003279_aneurysm | 1.87678927 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.86811969 |
| 27 | MP0003690_abnormal_glial_cell | 1.83738865 |
| 28 | MP0000920_abnormal_myelination | 1.81182011 |
| 29 | MP0005332_abnormal_amino_acid | 1.78776415 |
| 30 | MP0002254_reproductive_system_inflammat | 1.77679047 |
| 31 | MP0001958_emphysema | 1.76028096 |
| 32 | MP0009785_altered_susceptibility_to | 1.72655596 |
| 33 | MP0000609_abnormal_liver_physiology | 1.69802242 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.60369060 |
| 35 | MP0008469_abnormal_protein_level | 1.58530999 |
| 36 | MP0005025_abnormal_response_to | 1.56469826 |
| 37 | MP0008004_abnormal_stomach_pH | 1.54197211 |
| 38 | MP0003075_altered_response_to | 1.54195874 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.53421554 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.51322231 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.50519139 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.49496187 |
| 43 | MP0001542_abnormal_bone_strength | 1.45403234 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.45053106 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.43289610 |
| 46 | MP0006054_spinal_hemorrhage | 1.40910764 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.40475342 |
| 48 | MP0001790_abnormal_immune_system | 1.38378825 |
| 49 | MP0005387_immune_system_phenotype | 1.38378825 |
| 50 | MP0004510_myositis | 1.37307511 |
| 51 | MP0005595_abnormal_vascular_smooth | 1.37071412 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.36574873 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.32864686 |
| 54 | MP0009763_increased_sensitivity_to | 1.30663057 |
| 55 | MP0004270_analgesia | 1.29631869 |
| 56 | MP0003634_abnormal_glial_cell | 1.22828967 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.21208790 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19753697 |
| 59 | MP0003186_abnormal_redox_activity | 1.19175311 |
| 60 | MP0000685_abnormal_immune_system | 1.18384496 |
| 61 | MP0005275_abnormal_skin_tensile | 1.18220696 |
| 62 | MP0008874_decreased_physiological_sensi | 1.16566028 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.15542451 |
| 64 | MP0005166_decreased_susceptibility_to | 1.14738766 |
| 65 | MP0003828_pulmonary_edema | 1.14089775 |
| 66 | MP0003091_abnormal_cell_migration | 1.13088471 |
| 67 | MP0009697_abnormal_copulation | 1.13049827 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.11766086 |
| 69 | MP0003633_abnormal_nervous_system | 1.10961373 |
| 70 | MP0002723_abnormal_immune_serum | 1.10770589 |
| 71 | MP0001800_abnormal_humoral_immune | 1.10712917 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.10416973 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.09221262 |
| 74 | MP0005408_hypopigmentation | 1.08912745 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.07295562 |
| 76 | MP0004947_skin_inflammation | 1.06293077 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.05101654 |
| 78 | MP0005023_abnormal_wound_healing | 1.04845116 |
| 79 | MP0001853_heart_inflammation | 1.04369593 |
| 80 | MP0005164_abnormal_response_to | 1.04254493 |
| 81 | MP0002064_seizures | 1.03503838 |
| 82 | MP0003635_abnormal_synaptic_transmissio | 1.02608911 |
| 83 | MP0000343_altered_response_to | 1.02439558 |
| 84 | MP0001764_abnormal_homeostasis | 0.99971660 |
| 85 | MP0003868_abnormal_feces_composition | 0.99104597 |
| 86 | MP0003879_abnormal_hair_cell | 0.98202739 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.97661426 |
| 88 | MP0003329_amyloid_beta_deposits | 0.97656918 |
| 89 | MP0002063_abnormal_learning/memory/cond | 0.95972335 |
| 90 | MP0000598_abnormal_liver_morphology | 0.94487618 |
| 91 | MP0003011_delayed_dark_adaptation | 0.92147892 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.90596926 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.88463147 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.86930773 |
| 95 | MP0005423_abnormal_somatic_nervous | 0.84569571 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.82528681 |
| 97 | MP0004130_abnormal_muscle_cell | 0.82194630 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.81005642 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.80895415 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.80895415 |
| 101 | MP0005451_abnormal_body_composition | 0.80565892 |
| 102 | MP0004883_abnormal_blood_vessel | 0.79844684 |
| 103 | MP0000249_abnormal_blood_vessel | 0.79643111 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.79243921 |
| 105 | MP0003448_altered_tumor_morphology | 0.78109472 |
| 106 | MP0005535_abnormal_body_temperature | 0.77183493 |
| 107 | MP0002090_abnormal_vision | 0.77033522 |
| 108 | MP0003631_nervous_system_phenotype | 0.75908018 |
| 109 | MP0009745_abnormal_behavioral_response | 0.75014902 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.74906820 |
| 111 | MP0001970_abnormal_pain_threshold | 0.73593377 |
| 112 | MP0002933_joint_inflammation | 0.73560757 |
| 113 | MP0001819_abnormal_immune_cell | 0.73324436 |
| 114 | MP0005388_respiratory_system_phenotype | 0.72983369 |
| 115 | MP0002133_abnormal_respiratory_system | 0.72983369 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.72766245 |
| 117 | MP0000858_altered_metastatic_potential | 0.72653675 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.72559299 |
| 119 | MP0005647_abnormal_sex_gland | 0.72510536 |
| 120 | MP0005257_abnormal_intraocular_pressure | 0.72351940 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.70182469 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.70080872 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.70000349 |
| 124 | MP0003795_abnormal_bone_structure | 0.69969606 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.69892583 |
| 126 | MP0002928_abnormal_bile_duct | 0.66383509 |
| 127 | MP0005197_abnormal_uvea_morphology | 0.65644931 |
| 128 | MP0000371_diluted_coat_color | 0.65472712 |
| 129 | MP0000767_abnormal_smooth_muscle | 0.65434562 |
| 130 | MP0001851_eye_inflammation | 0.64438129 |
| 131 | MP0002006_tumorigenesis | 0.64292722 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.62127903 |
| 133 | MP0009278_abnormal_bone_marrow | 0.61414669 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.61061759 |
| 135 | MP0005390_skeleton_phenotype | 0.60523054 |
| 136 | MP0004858_abnormal_nervous_system | 0.60418080 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.60120739 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.59585089 |
| 139 | MP0008260_abnormal_autophagy | 0.59355938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.72590650 |
| 2 | Complement deficiency (HP:0004431) | 5.46955819 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.28878228 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.22928789 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.22928789 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.22928789 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.14471381 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.05417150 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.95514142 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.90000379 |
| 11 | Xanthomatosis (HP:0000991) | 4.86699376 |
| 12 | Joint hemorrhage (HP:0005261) | 4.83664926 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.74807357 |
| 14 | Mutism (HP:0002300) | 4.61771721 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.36643956 |
| 16 | Abnormality of complement system (HP:0005339) | 4.36595026 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.33978654 |
| 18 | Myocardial infarction (HP:0001658) | 4.23589742 |
| 19 | Glomerulonephritis (HP:0000099) | 4.14437001 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.97727003 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.96492973 |
| 22 | Epidermoid cyst (HP:0200040) | 3.73869214 |
| 23 | Hypercholesterolemia (HP:0003124) | 3.60718411 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58380370 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 3.54308203 |
| 26 | Prostate neoplasm (HP:0100787) | 3.45637304 |
| 27 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.42287461 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.25153517 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.21458428 |
| 30 | Loss of speech (HP:0002371) | 3.15323320 |
| 31 | Amyloidosis (HP:0011034) | 3.13502978 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.12584245 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.12174009 |
| 34 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.11141110 |
| 35 | Abnormality of macrophages (HP:0004311) | 3.08633797 |
| 36 | Fat malabsorption (HP:0002630) | 3.05412878 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.02666102 |
| 38 | Recurrent skin infections (HP:0001581) | 3.02102691 |
| 39 | Axonal loss (HP:0003447) | 3.00781001 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.86834504 |
| 41 | Abnormality of the frontal sinuses (HP:0002687) | 2.85436990 |
| 42 | Apathy (HP:0000741) | 2.84712778 |
| 43 | Skin nodule (HP:0200036) | 2.80996537 |
| 44 | Disinhibition (HP:0000734) | 2.79767019 |
| 45 | Nephritis (HP:0000123) | 2.78810061 |
| 46 | Gingival bleeding (HP:0000225) | 2.78033833 |
| 47 | Diminished motivation (HP:0000745) | 2.76312994 |
| 48 | Gingivitis (HP:0000230) | 2.74313473 |
| 49 | Esophageal varix (HP:0002040) | 2.73351959 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.72148018 |
| 51 | Neuronal loss in central nervous system (HP:0002529) | 2.62279126 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.61496677 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.60082046 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.59835762 |
| 55 | Steatorrhea (HP:0002570) | 2.59618519 |
| 56 | Spontaneous abortion (HP:0005268) | 2.59372451 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59025567 |
| 58 | Mitral stenosis (HP:0001718) | 2.50241056 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.48384886 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.48042914 |
| 61 | Hyperammonemia (HP:0001987) | 2.46309809 |
| 62 | Ketosis (HP:0001946) | 2.44826738 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.44432413 |
| 64 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43744652 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.43515512 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.41254850 |
| 67 | Retinal atrophy (HP:0001105) | 2.40564905 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.40052828 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.33874813 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32945089 |
| 71 | Myositis (HP:0100614) | 2.27458914 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27230717 |
| 73 | Hematochezia (HP:0002573) | 2.27080003 |
| 74 | Urticaria (HP:0001025) | 2.26095526 |
| 75 | Purpura (HP:0000979) | 2.25395548 |
| 76 | Tetraparesis (HP:0002273) | 2.21888660 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 2.21656782 |
| 78 | Optic neuritis (HP:0100653) | 2.21656782 |
| 79 | Menorrhagia (HP:0000132) | 2.21157989 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.19454237 |
| 81 | Periodontitis (HP:0000704) | 2.15360886 |
| 82 | Hyperglycinemia (HP:0002154) | 2.15135455 |
| 83 | Polyphagia (HP:0002591) | 2.13896700 |
| 84 | Thick nail (HP:0001805) | 2.12739014 |
| 85 | Protrusio acetabuli (HP:0003179) | 2.11028281 |
| 86 | Increased serum ferritin (HP:0003281) | 2.10538230 |
| 87 | Absent frontal sinuses (HP:0002688) | 2.09882287 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08231626 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.08231626 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07533795 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07533795 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07533795 |
| 93 | Pathologic fracture (HP:0002756) | 2.07042424 |
| 94 | Thrombophlebitis (HP:0004418) | 2.06683238 |
| 95 | Inappropriate behavior (HP:0000719) | 2.04272818 |
| 96 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04267664 |
| 97 | Malnutrition (HP:0004395) | 2.03993612 |
| 98 | Lower limb hyperreflexia (HP:0002395) | 2.03784879 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.02841657 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.02534081 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.02517608 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.02517608 |
| 103 | Hyperglycinuria (HP:0003108) | 1.96909430 |
| 104 | Peritonitis (HP:0002586) | 1.96323967 |
| 105 | Abnormality of the prostate (HP:0008775) | 1.96257482 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.94954079 |
| 107 | Dementia (HP:0000726) | 1.94712878 |
| 108 | Polycythemia (HP:0001901) | 1.92319719 |
| 109 | Stomatitis (HP:0010280) | 1.91974534 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.91805084 |
| 111 | Hepatocellular carcinoma (HP:0001402) | 1.91611939 |
| 112 | Peripheral demyelination (HP:0011096) | 1.90746326 |
| 113 | Agnosia (HP:0010524) | 1.89657437 |
| 114 | Hypoglycemic coma (HP:0001325) | 1.89002578 |
| 115 | Peripheral hypomyelination (HP:0007182) | 1.87984947 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.87813642 |
| 117 | Hypochromic microcytic anemia (HP:0004840) | 1.87726808 |
| 118 | Orchitis (HP:0100796) | 1.87631731 |
| 119 | Nuclear cataract (HP:0100018) | 1.86861362 |
| 120 | Metaphyseal dysplasia (HP:0100255) | 1.86761651 |
| 121 | Pulmonary embolism (HP:0002204) | 1.86513759 |
| 122 | Multiple lipomas (HP:0001012) | 1.86162734 |
| 123 | Conjunctival telangiectasia (HP:0000524) | 1.85082375 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82816315 |
| 125 | Abnormality of glycine metabolism (HP:0010895) | 1.82276057 |
| 126 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82276057 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.82209054 |
| 128 | Hemorrhage of the eye (HP:0011885) | 1.81473938 |
| 129 | Abnormal eating behavior (HP:0100738) | 1.76561074 |
| 130 | Prolonged neonatal jaundice (HP:0006579) | 1.75119865 |
| 131 | Cervical subluxation (HP:0003308) | 1.72959011 |
| 132 | Spondylolisthesis (HP:0003302) | 1.71689110 |
| 133 | Hyperventilation (HP:0002883) | 1.71628966 |
| 134 | Rapidly progressive (HP:0003678) | 1.70879376 |
| 135 | Action tremor (HP:0002345) | 1.69800326 |
| 136 | Thin bony cortex (HP:0002753) | 1.69717665 |
| 137 | Abnormality of the periventricular white matter (HP:0002518) | 1.69472007 |
| 138 | Memory impairment (HP:0002354) | 1.67339268 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.66130819 |
| 140 | Torticollis (HP:0000473) | 1.64869134 |
| 141 | Cerebral aneurysm (HP:0004944) | 1.64691927 |
| 142 | Hemoptysis (HP:0002105) | 1.64477332 |
| 143 | Premature rupture of membranes (HP:0001788) | 1.64342540 |
| 144 | Joint stiffness (HP:0001387) | 1.63487256 |
| 145 | Bone pain (HP:0002653) | 1.62742021 |
| 146 | Broad metatarsal (HP:0001783) | 1.61902809 |
| 147 | Ankle clonus (HP:0011448) | 1.60340902 |
| 148 | Aortic aneurysm (HP:0004942) | 1.60019202 |
| 149 | Metaphyseal irregularity (HP:0003025) | 1.58553062 |
| 150 | Absent speech (HP:0001344) | 1.58111615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.49977878 |
| 2 | TAOK3 | 3.34986470 |
| 3 | MAP3K14 | 3.32866038 |
| 4 | DDR2 | 3.32075885 |
| 5 | IRAK3 | 3.03825217 |
| 6 | TYK2 | 2.93478427 |
| 7 | ERN1 | 2.80330403 |
| 8 | TBK1 | 2.78603684 |
| 9 | MARK1 | 2.67892861 |
| 10 | KIT | 2.23252408 |
| 11 | SIK1 | 2.20044741 |
| 12 | CAMK1D | 2.19559476 |
| 13 | IRAK4 | 2.13633916 |
| 14 | IKBKE | 2.03008862 |
| 15 | ERBB4 | 1.96250729 |
| 16 | JAK3 | 1.94410205 |
| 17 | MAP3K13 | 1.93266025 |
| 18 | JAK1 | 1.93259774 |
| 19 | FGR | 1.82178198 |
| 20 | PRPF4B | 1.82165811 |
| 21 | CAMK1G | 1.78177619 |
| 22 | BLK | 1.78134553 |
| 23 | FGFR4 | 1.72060523 |
| 24 | SIK2 | 1.71129698 |
| 25 | PBK | 1.65053231 |
| 26 | CASK | 1.64258196 |
| 27 | INSRR | 1.62728780 |
| 28 | DAPK2 | 1.50921761 |
| 29 | TAOK1 | 1.50492791 |
| 30 | CDC42BPA | 1.48332940 |
| 31 | NEK9 | 1.47162258 |
| 32 | BCKDK | 1.46480514 |
| 33 | IKBKB | 1.46340759 |
| 34 | ARAF | 1.40012995 |
| 35 | TYRO3 | 1.38827987 |
| 36 | CSK | 1.38613797 |
| 37 | TAOK2 | 1.38025269 |
| 38 | JAK2 | 1.36823523 |
| 39 | ABL2 | 1.33942438 |
| 40 | TESK1 | 1.33832566 |
| 41 | TGFBR2 | 1.31274065 |
| 42 | MAP2K7 | 1.28962925 |
| 43 | CSF1R | 1.23925899 |
| 44 | PAK6 | 1.21206318 |
| 45 | NTRK2 | 1.16909640 |
| 46 | PDGFRB | 1.14476481 |
| 47 | MAP3K11 | 1.14134851 |
| 48 | MAP3K4 | 1.11898739 |
| 49 | FES | 1.11169026 |
| 50 | LIMK1 | 1.10959127 |
| 51 | MAP3K2 | 1.10378438 |
| 52 | MAP3K3 | 1.08623917 |
| 53 | BMPR2 | 1.05130274 |
| 54 | RIPK1 | 1.03413974 |
| 55 | PIM2 | 1.02917753 |
| 56 | NTRK3 | 1.02659537 |
| 57 | HCK | 1.01098998 |
| 58 | CHUK | 0.98794670 |
| 59 | MAP2K4 | 0.94683531 |
| 60 | PIK3CG | 0.93174544 |
| 61 | ADRBK2 | 0.92754683 |
| 62 | GRK7 | 0.92698971 |
| 63 | KSR2 | 0.90419481 |
| 64 | LATS2 | 0.88800472 |
| 65 | EGFR | 0.88458505 |
| 66 | MAP3K6 | 0.88068199 |
| 67 | KSR1 | 0.87264970 |
| 68 | CAMKK2 | 0.86767087 |
| 69 | MST1R | 0.84612365 |
| 70 | CAMK2G | 0.82553369 |
| 71 | LYN | 0.82405121 |
| 72 | PRKD2 | 0.79875936 |
| 73 | MARK2 | 0.77277469 |
| 74 | MAPK13 | 0.76667523 |
| 75 | CAMKK1 | 0.75847101 |
| 76 | MAPK7 | 0.75401633 |
| 77 | CAMK2B | 0.73555711 |
| 78 | MAP3K9 | 0.72951806 |
| 79 | NTRK1 | 0.71982074 |
| 80 | SYK | 0.71767914 |
| 81 | MAP3K1 | 0.71652261 |
| 82 | MAPK11 | 0.70433102 |
| 83 | ERBB2 | 0.69941404 |
| 84 | PRKCZ | 0.68576730 |
| 85 | ABL1 | 0.68439329 |
| 86 | IGF1R | 0.66400865 |
| 87 | SGK494 | 0.66095976 |
| 88 | SGK223 | 0.66095976 |
| 89 | LCK | 0.65889817 |
| 90 | MARK3 | 0.64528512 |
| 91 | CDK5 | 0.64266174 |
| 92 | CDK6 | 0.63740159 |
| 93 | PRKCD | 0.63470169 |
| 94 | PKN1 | 0.62458964 |
| 95 | PTK6 | 0.61534822 |
| 96 | STK38 | 0.61161923 |
| 97 | MAPK4 | 0.60684328 |
| 98 | MATK | 0.60073338 |
| 99 | PDPK1 | 0.59843178 |
| 100 | GRK5 | 0.59459492 |
| 101 | PRKAA2 | 0.58516009 |
| 102 | BMX | 0.58248249 |
| 103 | RAF1 | 0.56583530 |
| 104 | CSNK1G2 | 0.55972618 |
| 105 | MAP3K5 | 0.53587424 |
| 106 | ERBB3 | 0.52230714 |
| 107 | TXK | 0.52066006 |
| 108 | LATS1 | 0.51021336 |
| 109 | ZAP70 | 0.50811794 |
| 110 | CAMK2A | 0.50589130 |
| 111 | CAMK4 | 0.50561431 |
| 112 | FGFR3 | 0.50081082 |
| 113 | MAPK12 | 0.50014648 |
| 114 | EIF2AK2 | 0.49813179 |
| 115 | YES1 | 0.49542432 |
| 116 | TNK2 | 0.48679861 |
| 117 | FYN | 0.48407252 |
| 118 | IRAK2 | 0.47907975 |
| 119 | PRKCG | 0.47368847 |
| 120 | FRK | 0.45474113 |
| 121 | SGK3 | 0.45195924 |
| 122 | PDGFRA | 0.44700781 |
| 123 | ACVR1B | 0.44628332 |
| 124 | DMPK | 0.42813546 |
| 125 | EPHB2 | 0.42297724 |
| 126 | PRKACG | 0.41852227 |
| 127 | NME2 | 0.41817813 |
| 128 | MYLK | 0.41751810 |
| 129 | EPHA4 | 0.41445728 |
| 130 | GSK3A | 0.40673905 |
| 131 | MAP2K3 | 0.40616202 |
| 132 | RPS6KA4 | 0.39846377 |
| 133 | SGK1 | 0.39407966 |
| 134 | DYRK1B | 0.39238750 |
| 135 | EPHB1 | 0.38928213 |
| 136 | PDK1 | 0.38428782 |
| 137 | EPHA3 | 0.37682741 |
| 138 | SIK3 | 0.37668536 |
| 139 | PRKCQ | 0.37379014 |
| 140 | MAP4K1 | 0.37007779 |
| 141 | TTN | 0.36684061 |
| 142 | MOS | 0.36567647 |
| 143 | RPS6KA2 | 0.36550921 |
| 144 | PLK2 | 0.36417410 |
| 145 | TEC | 0.36128056 |
| 146 | SGK2 | 0.35863561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39254640 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.96262128 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.43229165 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26678423 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83823608 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64276648 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48186810 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25930110 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10687551 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92787255 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81144566 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80373084 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 1.76201363 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73037875 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72485458 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66571830 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58969557 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58118161 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53629512 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52549825 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52125533 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.48339071 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.42753654 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42252375 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40232824 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.38434461 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37202521 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33516965 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32502067 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26239352 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26049491 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24295152 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24010239 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.22030047 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20242945 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.16825283 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.15722224 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10032945 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07573852 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.06516553 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03590074 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.00516659 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00477414 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 0.99738377 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99202214 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98910065 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97718184 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.95225197 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.94468447 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93556977 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88909131 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88467808 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86152978 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85150919 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85128489 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84237512 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82795693 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82692250 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.78611033 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.78366087 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76412448 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73285101 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72358895 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71986549 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71411143 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71307712 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66606245 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66315013 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66180664 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64949637 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64769448 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63599802 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63508635 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62854536 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.62797124 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.60442540 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59306595 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58167892 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58009626 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57316404 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57000982 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.56107527 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55961837 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54950641 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54835003 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53780680 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53112465 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51840515 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51205414 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51006444 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50828696 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50124145 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.49937700 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49719974 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.49400850 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49366670 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48461220 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47873193 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.47306254 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.47253507 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.46674440 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46124351 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.45613876 |
| 104 | Measles_Homo sapiens_hsa05162 | 0.45230098 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44673489 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44657023 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43902859 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43174315 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.43171797 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43126528 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42185153 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40932549 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.40776778 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40408940 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40248753 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39522730 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.38784739 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38756174 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38152507 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38024640 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37842948 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37469977 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36978126 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36608235 |
| 125 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33271130 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32598437 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31658236 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31653393 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.29953240 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.28689297 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28421071 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26565612 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25699316 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22293038 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22112572 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20770996 |
| 137 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20449398 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.19274504 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19027516 |

